Post by Novo Nordisk
2,894,548 followers
#PRESS Our GLP-1 pill for the treatment of obesity and injectable semaglutide 7.2 mg is approved in the EU as we expand global access to obesity care. Read more here: https://lnkd.in/d6Xe8wD
2,894,548 followers
#PRESS Our GLP-1 pill for the treatment of obesity and injectable semaglutide 7.2 mg is approved in the EU as we expand global access to obesity care. Read more here: https://lnkd.in/d6Xe8wD